Navigation Links
Exelixis Announces June 2 Webcast of Its ASCO Investor and Analyst Briefing
Date:5/21/2008

Session: Developmental Therapeutics: Molecular Therapeutics

Time (Poster): 8 a.m.-noon Location: W375e Lobby

Time (Discussion): Noon-1 p.m. Location: W375a

Poster Number: 5 Abstract Number: 3528

Presenter: Heather A. Wakelee, MD

-- XL880* (MET, VEGFR2) -- Poster

"A phase 2 study of the dual MET/VEGFR2 inhibitor GSK1363089 (XL880)

in patients with papillary renal carcinoma (PRC)"

Day: Saturday, May 31

Session: Genitourinary Cancer

Time: 8 a.m.-noon

Location: S Hall A1

Poster Number: 5G Abstract Number: 5103

Presenter: Ramiprasad Srinivasan, MD, PhD

-- XL765 (PI3K, mTOR) -- Oral Presentation

"A phase 1 dose-escalation study of the safety, pharmacokinetics

(PK), and pharmacodynamics (PD) of a novel PI3K inhibitor, XL765,

administered orally to patients (pts) with advanced solid tumors"

Day: Saturday, May 31

Session: PI-3 Kinase/mTOR Directed Agents

Time: 1:45-2:15 pm

Location: W375a

Abstract Number: 3510

Presenter: Kyriakos Papadopoulis, MD

* XL880 was selected by GlaxoSmithKline in December 2007 for further

development and commercialization.

Sunday, June 1

-- XL184 (RET, MET, VEGFR2) -- Oral Presentation

"A phase 1 study of XL184, a RET, VEGFR2, and MET kinase inhibitor,

in patients (pts) with advanced malignancies, including pts with

medullary thyroid cancer (MTC)"

Day: Sunday, June 1

Session: Developmental Therapeutics: Molecular Therapeutics

Time: 10-10:15 a.m.

Location: W375a

Abstract Number: 3522

Presenter: Ravi Salgia, MD, PhD

-- XL647 (EGFR, HER2, VEGFR2) -- Poster

"Activity of XL647 in clinically selected NSCLC patients (pts)

'/>"/>
SOURCE Exelixis, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Dow AgroSciences and Exelixis Plant Sciences Announce Major Research Collaboration, Asset Purchase to Advance Gene Discovery and Validation
2. Exelixis Reports Encouraging Interim Data From a Phase 2 Trial of XL647 as First-Line Therapy for Non-Small Cell Lung Cancer
3. Exelixis Announces Closing of Public Offering of Common Stock
4. Exelixis Submits XL880 Diligence Report to GlaxoSmithKline
5. Exelixis Announces November 5 Webcast of its 2007 Third Quarter Financial Results Conference Call
6. Exelixis Announces Third Quarter 2007 Financial Results and Business Update
7. Exelixis Sells 80% Stake in Artemis to Taconic
8. Exelixis Announces December 5 Webcast of Its Third Annual R&D Day
9. Exelixis Announces November 27 Webcast of Presentation at the 19th Annual Piper Jaffray Health Care Conference
10. Exelixis Announces November 28 Webcast of Presentation at the Lazard Capital Markets Fourth Annual Healthcare Conference
11. Reminder: Exelixis Announces December 5 Webcast of Its Third Annual R&D Day

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...Calif.,Nov.23/PRNewswire/--PearlTherapeuticsInc.,a...ctsforthetreatmentofchronicrespiratorydiseases,tod...sBoardofDirectors.Mr.Rosenhas25yearsofexperiencein...ingkeyrolesatGileadSciencesandALZACorporation.Hisa...ardtosix. ,, "Howiebringsawealthofproductdevelo...
(Date:11/20/2009)..., , , , , , , ,...AUDIO: , A team of scientists from Washington...a, Cold Spring Harbor Laboratory and Iowa State Un...The... , , Click here for more in... , , , , , , , ...
(Date:11/20/2009)..., Nov. 20 Veridiam (www.veridiam.c...ize company category at the 2009 Workplace Excelle...ego Society for Human Resources Management and rec...practices. ,, Veridiam was one of nine winners,...mpanies, honored at the recent awards ceremony. Sa...
(Date:11/20/2009)...LE, Md., Nov. 20 Novavax...s priced an underwritten public offering of 6,800,...ublic of $3.30 per share. The approximately $21 m...riting discounts and commissions, will be used for...P-based vaccines, internal research and developmen...
Breaking Biology Technology:Pearl Therapeutics Appoints Howie Rosen to Board of Directors 2Amaizing: Corn genome decoded 2Amaizing: Corn genome decoded 3Amaizing: Corn genome decoded 4Veridiam Wins Workplace Excellence Crystal Award in Mid-Size Company Category 2Novavax Prices Public Offering of Common Stock 2
... Trusted LASIK Surgeons launched its revo... and website at www.TrustedLASIKSurgeons.com in ...to improve their vision. What sets the Trusted LAS...process ensuring that only those who are among the...n the United States are listed. Refractive eye sur...
... The Washington Life Sciences Discovery,Fund (LSDF...art-up phase of,the Washington Vaccine Alliance (W...w vaccines for E. coli, herpes and syphilis. Annou...0 million tobacco-lawsuit-settlement bonus,and pro...ew organization to,life. , WAVA core operati...
... Dec. 16 Fuld & Company today announced that ...vice president consulting, specializing in strateg...dustries. , , "We are excited to have Dr. R...president. "His extensive accomplishment in the gl...mia -- coupled with his involvement on the cutting...
Other Biology Technology:Hawaii LASIK Eye Surgery Expert Dr. John D. Olkowski Qualifies and Lists with Trusted LASIK Surgeons 2Hawaii LASIK Eye Surgery Expert Dr. John D. Olkowski Qualifies and Lists with Trusted LASIK Surgeons 3Hawaii LASIK Eye Surgery Expert Dr. John D. Olkowski Qualifies and Lists with Trusted LASIK Surgeons 4Hawaii LASIK Eye Surgery Expert Dr. John D. Olkowski Qualifies and Lists with Trusted LASIK Surgeons 5Hawaii LASIK Eye Surgery Expert Dr. John D. Olkowski Qualifies and Lists with Trusted LASIK Surgeons 6Hawaii LASIK Eye Surgery Expert Dr. John D. Olkowski Qualifies and Lists with Trusted LASIK Surgeons 7Life Sciences Discovery Fund Awards $4.7 Million to Support New Vaccine Program 2Life Sciences Discovery Fund Awards $4.7 Million to Support New Vaccine Program 3Life Sciences Discovery Fund Awards $4.7 Million to Support New Vaccine Program 4Fuld & Company Announces Appointment of MIT Fellow to Head Pharmaceutical Team's Strategic Gaming and Consulting Services 2
(Date:11/23/2009)...itute of General Medical Sciences (NIGMS), part of...ting $42.3 million for grants in scientific areas ...eveloped the GO grant program to stimulate biomedi...by the American Recovery and Reinvestment Act (Rec...promise to have a significant impact on a field of...
(Date:11/23/2009)... Casabona is Director of the Interuniversity Profe...iversity and the University of the Basque Country....ut also has other experts such as researchers in t...specialists in ethics. , The Interuniversity Pro...versities of Deusto and the Basque Country was cre...
(Date:11/23/2009)...available in German . , Of all global carbo...the atmosphere where it contributes to global warm...rrestrial ecosystems such as forests, grasslands a...aquatic and terrestrial ecosystems is considered o...cing climate change. However, new greenhouse gas b...
Breaking Biology News(10 mins):NIGMS invests in scientific Grand Opportunities with Recovery Act funds 2NIGMS invests in scientific Grand Opportunities with Recovery Act funds 3Research and legislation should go hand in hand, as much as possible 2Intensive land management leaves Europe without carbon sinks 2LSUHSC contributes to revealing targets to reduce racial disparity in prostate cancer deaths 53092 1LSUHSC contributes to revealing targets to reduce racial disparity in prostate cancer deaths 53092 2LSUHSC contributes to revealing targets to reduce racial disparity in prostate cancer deaths 53092 3Naming evolutions winners and losers 9412 1Naming evolutions winners and losers 9412 2Naming evolutions winners and losers 9412 3Scientists discover Amazon river is 11 million years old 9407 1
... Culminating a three-year research project, 115 s... 12 issue of the journal Science a "gold mine" of ...th implications for human diseases. , The single-...in soil and ponds, has approximately 15,000 genes,...e of its genome. Several years ago, they knew less...
...Researchers from University Hospitals (UH) Ireland... School of Medicine are part of a new national stu...ding 5,000 previously unmapped genes, from breast ...e by the journal Science on Oct. 11, shows a great...colon cancer tumors, leading the researchers to co...
...Climate change is a reality today, but how can we ...e really need is a full record of the Earths clima...th samples of air from different epochs that can b...record exists, in the icecaps of the Arctic and An... programme has a key role in deciphering it. , Pr...
Other Biology News:Study involving more than 100 scientists provides new insights on green algae 2Study involving more than 100 scientists provides new insights on green algae 3Study involving more than 100 scientists provides new insights on green algae 4European lead in reading past climates from ice cores 2European lead in reading past climates from ice cores 3
Nuclease S7; Micrococcal nuclease from Roche Applied Science
Mouse Anti-Human Porin 31HL Monoclonal Antibody, Unconjugated, Clone 89-173/016 from Calbiochem
Thermo Scientific Sorvall RC12BP low speed centrifuge from Thermo Scientific
...iptase is a recombinant Moloney murine leukemia vi...everse Transcriptase is similar to MuLV reverse tr...MuLV reverse transcriptase is a recombinant RNA-de...NA as a template in the presence of a primer to sy...
Biology Products: